Smart Drug Delivery Systems Companies Strategic Expansion Initiatives

Who are the Top Companies and What are Their Offerings?

All your Smart Drug Delivery Systems Market insights, streamlined and simplified - Buy Now

Recent Developments in the Market

• In March 2026, a wireless device, titled HOBIT (hybrid oxygenation bioelectronics system for implanted therapy), which successfully produces three different biologics that are anti-HIV antibody, leptin, and GLP-1-like peptide, was developed by a multi-institutional research team led by Northwestern University, making a significant breakthrough in implantable drug delivery systems.
• In March 2026, the first foldable next-gen pMDI (pressurised Metered Dose Inhaler) enhancer, that is Aerolife Mini™, was launched through the licensing arrangement between AeroDel Technology Innovations Pvt. Ltd. and Zydus Lifesciences Limited.

Market Value Chain Analysis

R&D

• The R&D of the smart drug delivery systems focuses on the integration of nanotechnology and AI into wearable and IoT-connected devices.
• Key players: Medtronic plc, Insulet Corporation, Novo Nordisk.

Clinical Trials and Regulatory Approvals

• The safety, dosing accuracy, and biocompatibility are evaluated in the clinical trials and regulatory approvals of the smart drug delivery systems.
• Key players: Medtronic plc, Insulet Corporation, Novo Nordisk

Packaging and Serialization

• The packing and serialization of the smart drug delivery systems involves the use of NFC tags, tamper-evident smart labels, and unique QR codes.
• Key players: Becton, Dickinson and Company, Gerresheimer AG, Schott Pharma.

Distribution to Hospitals, Pharmacies

• Specialized cold-chain logistics and automated pharmacy fulfilment networks are responsible for the distribution of the smart drug delivery systems to the hospital and pharmacies.
• Key players: Becton, Dickinson and Company, Medtronic plc, Baxter International Inc.

Patient Support and Services

• 24/7 technical helpdesk, digital training platforms, and integrated mobile apps are provided in the patient support and services of the smart drug delivery systems.
• Key players: Medtronic plc, Insulet Corporation, Novo Nordisk.

Market Trends

The global smart drug delivery systems market size was estimated at USD 78.6 billion in 2025 and is predicted to increase from USD 88.66 billion in 2026 to approximately USD 262.13 billion by 2035, expanding at a CAGR of 12.8% from 2026 to 2035. The growth in healthcare digitalization is increasing the adoption of smart drug delivery systems. Growing technological innovations, healthcare investments, a shift towards home healthcare, and new product launches are also enhancing the market growth.